x

Join Advarra

Learn more about our company team, careers, and values. Join Advarra’s Talented team to take on engaging work in a dynamic environment.

See Jobs

 
White Paper

Conducting Research With CAR T Cells

This white paper is a guide for research professionals looking to conduct CAR T cell studies for the first time, as well as for those seeking to expand their existing portfolio.

Read Now
Read more
 
White Paper

4 KPIs Clinical Research Study Managers Can Master

This white paper examines four KPIs most impacting timelines and budgets and offers strategies for effective communication and risk mitigation.

Read Now
Read more
 
White Paper

CAR T Manufacturing and Toxicity

Find out what FDA guidance says about integrating gene delivery vectors, such as CAR T cells, and gene editing technologies (like CRISPR).

Read Now
Read more
 
White Paper

sIRB Review for Multicenter Research: A Guide for Institutions

February 15, 2024

Single IRB (sIRB) review for multicenter research is fast becoming the norm in the US. Initiative such as the NIH sIRB policy and revised Common Rule make it clear that ...

Read Now
Read more
 
White Paper

Operationalizing Research Analytics: Today, Tomorrow, Someday

Uncover how analytics, artificial intelligence, and machine learning are reshaping the foundational elements of clinical research.

Read Now
Read more
 
White Paper

GxP Compliance in Clinical Research

This white paper walks through key GxP principles and regulatory requirements and gives a real-world case study.

Read Now
Read more
 
White Paper

4 Modernized Functions Every Sponsor Needs for Study Startup

This white paper outlines four technology capabilities sponsors need to expedite the study startup process.

Read Now
Read more
 
White Paper

Navigating Key Complexities in the Development of Cell and Gene Therapies

Explore the uniquely complex regulatory guidelines and challenges cell and gene therapy presents in research.

Read Now
Read more
 
White Paper

Data on the go: Mobile Application Considerations for Clinical Trials and Beyond

Find out the necessary regulatory and ethical considerations when utilizing an app or connected device in human subjects research.

Read Now
Read more
 
White Paper

Unique First-in-Human Phase I IRB Considerations you Might not Know About

An institutional review board (IRB) may ask some different questions for first-in-human (FIH) Phase I trials than later phase studies.

Read Now
Read more
 
White Paper

Understanding how to Build and Leverage a DSMB Statistical Plan

Find out about the DSMB statistician’s roles, how study design can impact DSMB analysis, and what goes into a DSMB statistical plan.

Read Now
Read more
 
White Paper

Rare and Orphan Diseases: Choosing a Path to Regulatory Approval and Market Success

Explore the regulatory challenges and pathway guidance for sponsors bringing innovative rare and orphan therapies to market.

Read Now
Read more